propofol has been researched along with Anesthesia Related Hyperthermia in 56 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In case 1, a 19-year-old, 59-kg man with Becker muscular dystrophy and mental retardation was scheduled for dental treatment under general anesthesia." | 5.33 | Continuous infusion propofol general anesthesia for dental treatment in patients with progressive muscular dystrophy. ( Kawaai, H; Tanaka, K; Yamazaki, S, 2005) |
| " The appearance of muscle spasms as a result of the use of propofol, forced us into a second anaesthesia to perform total intravenous anaesthesia with Midazolam." | 3.85 | General anesthesia in patients with syndrome of Poland. ( Díaz-Crespo, J; García-Herrera, F; Vázquez-Mambrilla, Y, 2017) |
| " Anesthesia was induced with propofol using a target controlled infusion." | 3.72 | [Difficult tracheal intubation in a patient suspected of malignant hyperthermia]. ( Ikeda, S; Murao, K; Nikaido, Y; Sakamoto, S; Shingu, K; Uchiyama, Y, 2003) |
| " We present a detailed description of the case and also discuss the role of propofol and rhabdomyolysis." | 3.72 | A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis. ( Green, G, 2003) |
| " In vitro, human MHS muscle samples were exposed to propofol and changes in (a) baseline tension and (b) contracture tension on exposure to halothane and caffeine were measured." | 3.68 | Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. ( Couchman, KG; McKenzie, AJ; Pollock, N, 1992) |
| "Malignant hyperthermia is a rare pharmacogenetic syndrome characterized by a severe hypermetabolic reaction after the administration of halogenated inhalational anesthetics or depolarizing muscle relaxants such as succinylcholine, or both." | 1.56 | MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT. ( Almeida, CG; Colleti Junior, J, 2020) |
| "The diagnosis of malignant hyperthermia (MH) susceptibility could be confirmed in the patient 4 months after the acute event by the in vitro contracture test and detection of the MH causative mutation p." | 1.48 | [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine]. ( Helf, D; Johannsen, S; Markus, CK; Schneiderbanger, D; Schuster, F, 2018) |
| "We present 2 cases of fulminant malignant hyperthermia (MH), complicated with massive rhabdomyolysis." | 1.39 | Continuous veno-venous hemofiltration for massive rhabdomyolysis after malignant hyperthermia: report of 2 cases. ( Fang, S; Jiang, H; Xu, H; Zhu, Y, 2013) |
| "Malignant hyperthermia is a pharmacogenetic skeletal muscle disorder of intracellular calcium (Ca2+) homeostasis with an autosomal dominant inheritance." | 1.35 | Effects of propofol on calcium homeostasis in human skeletal muscle. ( Hamada, H; Kawamoto, M; Kobayashi, M; Migita, T; Mukaida, K; Nishino, I; Yuge, O, 2009) |
| "Malignant hyperthermia is a pharmacogenetic disorder caused by autosomal dominant mutations in the ryanodine receptor type 1 gene." | 1.34 | Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers. ( Kawamoto, M; Kobayashi, M; Migita, T; Mukaida, K; Nishino, I; Yuget, O, 2007) |
| "In case 1, a 19-year-old, 59-kg man with Becker muscular dystrophy and mental retardation was scheduled for dental treatment under general anesthesia." | 1.33 | Continuous infusion propofol general anesthesia for dental treatment in patients with progressive muscular dystrophy. ( Kawaai, H; Tanaka, K; Yamazaki, S, 2005) |
| " Reproducible shifts in the dose-response of skeletal muscle to caffeine and halothane are the basis of the current in vitro diagnostic caffeine-halothane contracture test." | 1.33 | Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis. ( Bina, S; Bünger, R; Cowan, G; Karaian, J; Mongan, P; Muldoon, S, 2006) |
| "A relatively high incidence of malignant hyperthermia (MH) and an unpredicted (usually increased) sensitivity to muscle relaxants are reported in patients with congenital myopathies (CM)." | 1.32 | [Anesthesia for laparoscopic cryptorchidpexy in a patient with congenital myopathy]. ( Miyamoto, E; Murao, K; Nakao, S; Shingu, K; Uchiyama, Y; Yamada, M, 2003) |
| "He previously had an episode suggesting malignant hyperthermia susceptibility during anesthesia managed with suxamethonium and isoflurane." | 1.31 | [A case of high dose administration of propofol]. ( Kinuwaki, H; Nishioka, H; Shimoda, O; Terasaki, H, 2000) |
| "The mitochondrial myopathies are a rare group of conditions affecting the respiratory chain and oxidative phosphorylation." | 1.30 | Anesthesia for a child with complex I respiratory chain enzyme deficiency. ( Cheam, EW; Critchley, LA, 1998) |
| "In contrast to malignant hyperthermia-triggering inhalation anesthetics, propofol does not stimulate malignant hyperthermia-susceptible or normal ryanodine receptor channel activity, even at > 100 times clinical concentrations." | 1.29 | Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes. ( Fruen, BR; Litterer, LA; Louis, CF; Mickelson, JR; Roghair, TJ, 1995) |
| "The symptoms are those of malignant hyperpyrexia (MH)." | 1.29 | [Use of Diprivan in muscular diseases and malignant hyperthermia]. ( Adnet, P, 1994) |
| "2." | 1.28 | Propofol anaesthesia in malignant hyperpyrexia susceptible swine. ( Denborough, MA; Foster, PS; Hopkinson, KC, 1992) |
| "There was no evidence of malignant hyperthermia during the procedure and cardiovascular stability was excellent." | 1.28 | [The use of propofol in a female patient predisposed to malignant hyperthermia (central core disease)]. ( Fontana, G; Motta, F; Ostaldo, M; Riedo, R; Rivolta, M, 1992) |
| "The anesthetic technique chosen for a malignant hyperthermia (MH) susceptible patient should include drugs that do not trigger MH, while providing stress-free conditions." | 1.28 | Propofol anesthesia in the malignant hyperthermia susceptible patient. ( Klotz, RW, 1991) |
| "Mean onset time of malignant hyperthermia on exposure to halothane alone was 7." | 1.28 | The screening of propofol in MHS swine. ( Harrison, GG; Raff, M, 1989) |
| "Anaesthetic techniques for malignant hyperthermia susceptible (MHS) patients should include drugs which do not trigger MH and provide stress free conditions." | 1.28 | Effect of propofol on the malignant hyperthermia susceptible pig model. ( Adnet, P; Becq, MC; Krivosic-Horber, R; Reyfort, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (10.71) | 18.7374 |
| 1990's | 24 (42.86) | 18.2507 |
| 2000's | 15 (26.79) | 29.6817 |
| 2010's | 9 (16.07) | 24.3611 |
| 2020's | 2 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, CG | 1 |
| Colleti Junior, J | 1 |
| Watanabe, T | 1 |
| Miyoshi, H | 1 |
| Noda, Y | 1 |
| Narasaki, S | 1 |
| Morio, A | 1 |
| Toyota, Y | 1 |
| Kimura, H | 1 |
| Mukaida, K | 3 |
| Yasuda, T | 1 |
| Tsutsumi, YM | 1 |
| Helf, D | 1 |
| Schneiderbanger, D | 1 |
| Markus, CK | 1 |
| Johannsen, S | 1 |
| Schuster, F | 1 |
| Fang, S | 1 |
| Xu, H | 1 |
| Zhu, Y | 1 |
| Jiang, H | 1 |
| Freiermuth, D | 1 |
| Poblete, B | 1 |
| Singer, M | 1 |
| Konrad, CJ | 1 |
| Girard, T | 1 |
| Galgano, M | 1 |
| Briggs, D | 1 |
| Marawar, S | 1 |
| Calancie, B | 1 |
| Schaff, J | 1 |
| Maniker, R | 1 |
| Díaz-Crespo, J | 1 |
| Vázquez-Mambrilla, Y | 1 |
| García-Herrera, F | 1 |
| Schwartz, D | 1 |
| Raghunathan, K | 1 |
| Migita, T | 2 |
| Hamada, H | 1 |
| Kobayashi, M | 2 |
| Nishino, I | 2 |
| Yuge, O | 1 |
| Kawamoto, M | 2 |
| Dhaese, HL | 1 |
| Martens, PR | 1 |
| Müller, NH | 1 |
| Casier, IM | 1 |
| Mulier, JP | 1 |
| Heytens, L | 1 |
| Murao, K | 3 |
| Umegaki, T | 1 |
| Masuzawa, M | 1 |
| Inoue, S | 1 |
| Nakao, S | 2 |
| Shingu, K | 3 |
| Stoll, WD | 1 |
| Hebbar, L | 1 |
| Marica, LS | 1 |
| Sugino, S | 1 |
| Yamazaki, Y | 1 |
| Nawa, Y | 1 |
| Sato, K | 1 |
| Sonoda, H | 1 |
| Namiki, A | 1 |
| Nikaido, Y | 1 |
| Ikeda, S | 1 |
| Sakamoto, S | 1 |
| Uchiyama, Y | 2 |
| Green, G | 1 |
| Guasch, E | 1 |
| Civantos, B | 1 |
| Aguilar, JM | 1 |
| Torres, MD | 2 |
| Gilsanz, F | 1 |
| Miyamoto, E | 1 |
| Yamada, M | 1 |
| Oue, T | 1 |
| Nishimoto, M | 1 |
| Kitaura, M | 1 |
| Samuta, T | 1 |
| Toda, N | 1 |
| Koyama, Y | 1 |
| Inoue, K | 1 |
| Danura, T | 1 |
| Kawaai, H | 1 |
| Tanaka, K | 1 |
| Yamazaki, S | 1 |
| Bina, S | 1 |
| Cowan, G | 1 |
| Karaian, J | 1 |
| Muldoon, S | 1 |
| Mongan, P | 1 |
| Bünger, R | 1 |
| Hudcova, J | 1 |
| Schumann, R | 1 |
| Yuget, O | 1 |
| del Valle, V | 1 |
| Trigo Rubio, P | 1 |
| Bermejo Alvarez, MA | 1 |
| Taboada, C | 1 |
| Price, SR | 1 |
| Currie, J | 1 |
| Fruen, BR | 1 |
| Mickelson, JR | 1 |
| Roghair, TJ | 1 |
| Litterer, LA | 1 |
| Louis, CF | 1 |
| Adnet, P | 2 |
| Freedman, G | 1 |
| Sampson, IH | 1 |
| Cagen, S | 1 |
| Khan, KJ | 1 |
| Cooper, GM | 1 |
| Bowie, JR | 1 |
| Fernández-Esplá, A | 1 |
| Baeza, C | 1 |
| Torres, C | 1 |
| Soler, G | 1 |
| Plötz, FB | 2 |
| Waalkens, HJ | 2 |
| Verkade, HJ | 2 |
| Strengers, JL | 1 |
| Knoester, H | 1 |
| Mandema, JM | 1 |
| Neff, SP | 1 |
| Futter, ME | 1 |
| Anderson, BJ | 1 |
| Pollock, AN | 1 |
| McKenzie, AJ | 2 |
| Hodges, M | 1 |
| Snoeck, MM | 1 |
| Cheam, EW | 1 |
| Critchley, LA | 1 |
| Burgos-Asurmendi, I | 1 |
| Guerra-González, ML | 1 |
| Canseco-Dansey, I | 1 |
| Lojo-Sánchez, D | 1 |
| Sáez Cuevas, E | 1 |
| Hawkes, CA | 1 |
| Cruz, JI | 1 |
| Burzaco, O | 1 |
| Campoy, L | 1 |
| Ruiz, J | 1 |
| Escartin, A | 1 |
| García-Gil, FA | 1 |
| Nishioka, H | 1 |
| Kinuwaki, H | 1 |
| Shimoda, O | 1 |
| Terasaki, H | 1 |
| Wootton, MA | 1 |
| Lockie, J | 1 |
| Foster, PS | 1 |
| Hopkinson, KC | 2 |
| Denborough, MA | 1 |
| Kumata, DS | 1 |
| Couchman, KG | 1 |
| Pollock, N | 1 |
| Rivolta, M | 1 |
| Riedo, R | 1 |
| Ostaldo, M | 1 |
| Fontana, G | 1 |
| Motta, F | 1 |
| Harrison, GG | 2 |
| Gallen, JS | 1 |
| Rolle, L | 1 |
| Belluomo-Anello, C | 1 |
| Viglietto, A | 1 |
| D'Ari, G | 1 |
| Allen, G | 1 |
| Klotz, RW | 1 |
| Cartwright, DP | 1 |
| Raff, M | 1 |
| Krivosic-Horber, R | 1 |
| Reyfort, H | 1 |
| Becq, MC | 1 |
| Denborough, M | 1 |
| Marks, LF | 1 |
| Edwards, JC | 1 |
| Linter, SP | 1 |
| Richardson, J | 1 |
56 other studies available for propofol and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT.
Topics: Acyclovir; Anesthetics, Inhalation; Anesthetics, Intravenous; Antiviral Agents; Child, Preschool; Da | 2020 |
Effects of Remimazolam and Propofol on Ca
Topics: Anesthetics; Benzodiazepines; Caffeine; Calcium; HEK293 Cells; Humans; Malignant Hyperthermia; Mutat | 2021 |
[Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
Topics: Anesthesia, General; Anesthetics, Intravenous; Dantrolene; Female; Fentanyl; Humans; Malignant Hyper | 2018 |
Continuous veno-venous hemofiltration for massive rhabdomyolysis after malignant hyperthermia: report of 2 cases.
Topics: Acute Kidney Injury; Adolescent; Adult; Anesthesia, Dental; Anesthesia, General; Anesthetics, Intrav | 2013 |
Difficult diagnosis of malignant hyperthermia during laparoscopic surgery.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Desflurane; DNA Mutational Analysis; Drug S | 2013 |
A Case of Malignant Hyperthermia Captured by Neuromonitoring During a Lumbar Endoscopic Discectomy.
Topics: Anesthetics, Intravenous; Dantrolene; Diskectomy; Electromyography; Endoscopy; Fentanyl; Fluid Thera | 2016 |
Anesthetic management of donor nephrectomy for a recipient with history of malignant hyperthermia: avoiding a transferred trigger.
Topics: Androstanols; Anesthetics, Intravenous; Female; Humans; Kidney Transplantation; Living Donors; Malig | 2016 |
General anesthesia in patients with syndrome of Poland.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenous; Breast; Breast Im | 2017 |
Anesthesia and mitochondrial disorders.
Topics: Anesthesia; Anesthetics, Intravenous; Child; Contraindications; Humans; Malignant Hyperthermia; Mito | 2009 |
Effects of propofol on calcium homeostasis in human skeletal muscle.
Topics: Adolescent; Adult; Aged; Anesthetics, Intravenous; Caffeine; Calcium; Child; Child, Preschool; Dose- | 2009 |
The use of emergency medical cooling system pads in the treatment of malignant hyperthermia.
Topics: Anesthesiology; Anesthetics, Inhalation; Atracurium; Humans; Hypothermia, Induced; Male; Malignant H | 2010 |
[Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH].
Topics: Anesthesia, Intravenous; Anesthetics, Combined; Body Temperature; Colectomy; Female; Fentanyl; Human | 2010 |
Anesthetic management of a pregnant patient with multiple pterygium syndrome (Escobar type).
Topics: Abnormalities, Multiple; Adult; Analgesics; Anesthesia, General; Anesthetics, Inhalation; Anesthetic | 2012 |
[Anesthetic management for a patient with Charcot-Marie-Tooth disease using propofol and nitrous oxide].
Topics: Aged; Anesthesia, General; Charcot-Marie-Tooth Disease; Female; Humans; Intraoperative Complications | 2002 |
[Difficult tracheal intubation in a patient suspected of malignant hyperthermia].
Topics: Anesthesia; Anesthetics, Intravenous; Fentanyl; Humans; Intubation, Intratracheal; Laryngeal Masks; | 2003 |
A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis.
Topics: Adult; Anesthetics, Intravenous; Compartment Syndromes; Dantrolene; Fatal Outcome; Hemorrhage; Human | 2003 |
Progressive external ophthalmoplegia and ambulatory remifentanil-propofol based anaesthesia.
Topics: Ambulatory Surgical Procedures; Anesthetics, Combined; Anesthetics, Intravenous; Female; Humans; Mal | 2003 |
[Anesthesia for laparoscopic cryptorchidpexy in a patient with congenital myopathy].
Topics: Anesthesia, Epidural; Anesthesia, General; Cryptorchidism; Humans; Infant; Intraoperative Complicati | 2003 |
[Anesthetic management of a child with Schwartz-Jampel syndrome].
Topics: Anesthesia, General; Anesthetics, Inhalation; Child; Contraindications; Humans; Laryngeal Masks; Low | 2004 |
Continuous infusion propofol general anesthesia for dental treatment in patients with progressive muscular dystrophy.
Topics: Adult; Anesthesia, Dental; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenou | 2005 |
Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Topics: Anesthesia, General; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenous; A | 2006 |
Undiagnosed catecholamine-secreting paraganglioma and coexisting carcinoid in a patient with MH susceptibility: an unusual anesthetic challenge.
Topics: Adrenergic alpha-Agonists; Adult; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenou | 2007 |
Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers.
Topics: Adolescent; Anesthetics, Intravenous; Calcium; Cells, Cultured; Female; Humans; Male; Malignant Hype | 2007 |
[Anesthetic considerations in nemaline myopathy].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Atropine; Contraindications; Humans; Intra | 2008 |
Anaesthesia for a child with centronuclear myopathy.
Topics: Anesthesia, General; Anesthetics, Intravenous; Child; Cryptorchidism; Humans; Male; Malignant Hypert | 1995 |
Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes.
Topics: Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Calcium-Transporting ATPases; Malignan | 1995 |
[Use of Diprivan in muscular diseases and malignant hyperthermia].
Topics: Anesthesia, Intravenous; Humans; Malignant Hyperthermia; Monitoring, Intraoperative; Muscular Diseas | 1994 |
Propofol use in malignant hyperthermia: a case report.
Topics: Adult; Female; Humans; Malignant Hyperthermia; Propofol | 1993 |
Propofol and malignant hyperthermia: a case for day-case anaesthesia?
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, General; Female; Humans; Malignant Hyperthermia; | 1993 |
Patients who are susceptible to malignant hyperthermia.
Topics: Cleft Lip; Female; Humans; Infant; Malignant Hyperthermia; Propofol | 1993 |
[Anesthesia in a case of mitochondrial myopathy].
Topics: Acidosis, Lactic; Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalation; A | 1996 |
Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia.
Topics: Child; Fatal Outcome; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Male; Malignant Hyper | 1996 |
Fatal outcome after propofol sedation in children.
Topics: Acidosis; Arrhythmias, Cardiac; Cardiac Output, Low; Cause of Death; Child; Creatine Kinase; Dantrol | 1997 |
Propofol and malignant hyperthermia susceptibility.
Topics: Acidosis; Adolescent; Adult; Aged; Anesthetics, Intravenous; Arrhythmias, Cardiac; Cause of Death; C | 1997 |
Fatal outcome after propofol sedation in children.
Topics: Anesthetics, Intravenous; Cause of Death; Child; Dantrolene; Disease Susceptibility; Humans; Hypnoti | 1997 |
Anesthesia for a child with complex I respiratory chain enzyme deficiency.
Topics: Anesthesia; Child; Electron Transport Complex I; Female; Humans; Malignant Hyperthermia; Mitochondri | 1998 |
[Apropos of a case of facioscapulohumeral dystrophy or Landouzy-Déjerine disease].
Topics: Adolescent; Anesthesia, Intravenous; Anesthesia, Spinal; Anesthetics, Intravenous; Anesthetics, Loca | 1999 |
Factitious halothane detection during trigger-free anesthesia in a malignant hyperthermia susceptible patient.
Topics: Adult; Anesthetics, Intravenous; Anesthetics, Local; Arthrodesis; Arthroscopy; Disease Susceptibilit | 1999 |
Intravenous anesthesia with propofol for liver transplantation in pigs.
Topics: Anesthesia, Intravenous; Anesthetics, Intravenous; Animals; Liver Transplantation; Malignant Hyperth | 1999 |
[A case of high dose administration of propofol].
Topics: Adult; Anesthesia, General; Cholesterol; Dantrolene; Humans; Male; Malignant Hyperthermia; Postopera | 2000 |
Anaesthetic management of a child with a positive family history of malignant hyperthermia for posterior fossa surgery in the sitting position.
Topics: Anesthesia; Anesthesia, Intravenous; Anesthetics, Intravenous; Cerebellar Neoplasms; Child; Cranial | 2001 |
Propofol anaesthesia in malignant hyperpyrexia susceptible swine.
Topics: Anesthesia; Animals; Caffeine; Female; Halothane; Injections, Intravenous; Male; Malignant Hyperther | 1992 |
Propofol and malignant hyperthermia.
Topics: Animals; Humans; Malignant Hyperthermia; Propofol | 1992 |
Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
Topics: Adolescent; Adult; Anesthesia, Intravenous; Caffeine; Contracture; Disease Susceptibility; Halothane | 1992 |
[The use of propofol in a female patient predisposed to malignant hyperthermia (central core disease)].
Topics: Adult; Causality; Female; Humans; Malignant Hyperthermia; Propofol | 1992 |
Propofol in malignant hyperthermia.
Topics: Anesthesia; Biopsy; Disease Susceptibility; Humans; In Vitro Techniques; Malignant Hyperthermia; Mus | 1991 |
Propofol does not trigger malignant hyperthermia.
Topics: Adolescent; Humans; Male; Malignant Hyperthermia; Propofol | 1991 |
[Propofol in the anesthesia of patients at risk of malignant hyperthermia in pediatric ophthalmic surgery].
Topics: Child; Child, Preschool; Female; Humans; Male; Malignant Hyperthermia; Propofol; Risk Factors; Strab | 1991 |
Propofol and malignant hyperthermia.
Topics: Anesthesia, Intravenous; Animals; Contraindications; Humans; Malignant Hyperthermia; Propofol | 1991 |
Propofol anesthesia in the malignant hyperthermia susceptible patient.
Topics: Adult; Female; Humans; Infusions, Intravenous; Malignant Hyperthermia; Molar; Propofol; Tooth, Impac | 1991 |
Propofol in patients susceptible to malignant hyperpyrexia.
Topics: Anesthetics; Disease Susceptibility; Female; Humans; Malignant Hyperthermia; Middle Aged; Phenols; P | 1989 |
The screening of propofol in MHS swine.
Topics: Anesthetics; Animals; Halothane; Malignant Hyperthermia; Phenols; Propofol; Swine | 1989 |
Effect of propofol on the malignant hyperthermia susceptible pig model.
Topics: Anesthetics; Animals; Disease Models, Animal; Disease Susceptibility; Malignant Hyperthermia; Phenol | 1989 |
Propofol and malignant hyperpyrexia.
Topics: Anesthetics; Animals; Humans; Malignant Hyperthermia; Phenols; Propofol; Swine | 1988 |
Propofol during cardiopulmonary bypass in a patient susceptible to malignant hyperpyrexia.
Topics: Adult; Anesthesia; Anesthetics; Cardiopulmonary Bypass; Humans; Male; Malignant Hyperthermia; Phenol | 1988 |
Propofol infusion for coronary artery bypass surgery in a patient with suspected malignant hyperpyrexia.
Topics: Anesthesia, Intravenous; Anesthetics; Coronary Artery Bypass; Humans; Male; Malignant Hyperthermia; | 1987 |